Expert Review of Pharmacoeconomics & Outcomes Research

医学 药学

  • 影响指数：2.037
  • 中科院分区：医学 4区 医学 4 区
  • 审稿周期：暂无数据
  • 自引率：15.3%
  • 录取率：
  • ISSN：2190-572X
  • 发刊频率：暂无数据
  • 年文章数：454
  • 国人占比：2.56%
  • 期刊网址：点击查看
  • 研究方向：暂无数据
  • 期刊攻略
  • IF变化趋势
  • 期刊占比
  • 最新文章

期刊简介

3 BIOTECH杂志暂不明确行业，暂不明确子行业的级别不明杂志

收稿要求

暂无数据

建议

杂志水平一般，也很冷门，关注人少，审稿周期可能也不一定快，如果文章质量不佳，或时间不紧的话，可以考虑考虑。

Direct medical and indirect absenteeism costs among working adult ADHD patients in the United States.

DOI：10.1080/14737167.2022.2073223

发表时间：2022 May 11

作者：Shah CH；Onukwugha E

Summary of the 2020 AHRQ research meeting on 'advancing methods of implementing and evaluating patient experience improvement using consumer assessment of healthcare providers and systems (CAHPS®) surveys'.

DOI：10.1080/14737167.2022.2064848

发表时间：2022 May 5

作者：Quigley D；Qureshi N；Rybowski L；Shaller D；Edgman-Levitan S；Cleary PD；Ginsberg C；Hays RD

Cost-effectiveness analysis of donafenib versus lenvatinib for first-line treatment of unresectable or metastatic hepatocellular carcinoma.

DOI：10.1080/14737167.2022.2079498

发表时间：2022 May 26

作者：Meng R；Zhang X；Zhou T；Luo M；Qiu Y

Examining the correlation between treatment effects in clinical trials and economic modelling.

DOI：10.1080/14737167.2022.2079497

发表时间：2022 May 18

作者：Xie X；Wang M；Gajic-Veljanoski O；Ye C；Blumberger DM；Volodin A

Cost-effectiveness analysis of molecular diagnosis by next-generation sequencing versus sequential single testing in metastatic non-small cell lung cancer patients from a south Spanish hospital perspective.

DOI：10.1080/14737167.2022.2078310

发表时间：2022 May 25

作者：de Alava E；Pareja MJ；Carcedo D；Arrabal N；García JF；Bernabé-Caro R

公众号